Core Laboratories NV logo

CLB - Core Laboratories NV Share Price

$34.55 -0.1  -0.3%

Last Trade - 03/03/21

Mid Cap
Market Cap £1.11bn
Enterprise Value £1.29bn
Revenue £349.2m
Position in Universe 2420th / 6643
Unlock CLB Revenue
Relative Strength (%)
1m +1.65%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -9.08%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
797.5 590.2 647.8 700.8 668.2 487.3 480.7 525.8 -9.4%
-46.5 -52.1 +24.9 -3.4 +16.9 +44.4
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, CoreLaboratories N.V. revenues decreased 27% to $487.3M. Netloss before extraordinary items totaled $97.2M vs. incomeof $94.2M. Revenues reflect Production Enhancement segmentdecrease of 47% to $132.2M, Reservoir Description segmentdecrease of 16% to $355M, United States segment decrease of45% to $158.9M, Other Countries segment decrease of 7% to$328.3M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CLB Revenue Unlock CLB Revenue

Net Income

CLB Net Income Unlock CLB Revenue

Normalised EPS

CLB Normalised EPS Unlock CLB Revenue

PE Ratio Range

CLB PE Ratio Range Unlock CLB Revenue

Dividend Yield Range

CLB Dividend Yield Range Unlock CLB Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CLB EPS Forecasts Unlock CLB Revenue
Profile Summary

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated July 8, 1994
Public Since July 10, 1998
No. of Shareholders: 219
No. of Employees: 3,700
Sector Energy
Industry Oil & Gas Related Equipment and Services
Index S&P 600 Small Cap , S&P Composite 1500 ,
Exchange New York Stock Exchange
Shares in Issue 44,573,622
Free Float (0.0%)
Eligible for
CLB Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CLB
Upcoming Events for CLB
Tuesday 20th April, 2021 Estimate
Q1 2021 Core Laboratories NV Earnings Release
Frequently Asked Questions for Core Laboratories NV
What is the Core Laboratories NV share price?

As of 03/03/21, shares in Core Laboratories NV are trading at $34.55, giving the company a market capitalisation of £1.11bn. This share price information is delayed by 15 minutes.

How has the Core Laboratories NV share price performed this year?

Shares in Core Laboratories NV are currently trading at $34.55 and the price has moved by 25.4% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Core Laboratories NV price has moved by -3.48% over the past year.

What are the analyst and broker recommendations for Core Laboratories NV?

Of the analysts with advisory recommendations for Core Laboratories NV, there are there are currently 1 "buy" , 8 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Core Laboratories NV is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Core Laboratories NV next release its financial results?

Core Laboratories NV is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Core Laboratories NV dividend yield?

The Core Laboratories NV dividend yield is 0.81% based on the trailing twelve month period.

Does Core Laboratories NV pay a dividend?

Last year, Core Laboratories NV paid a total dividend of 0.28, and it currently has a trailing dividend yield of 0.81%. Looking ahead, Core Laboratories NV has not announced an ex-dividend date yet.

When does Core Laboratories NV next pay dividends?

Core Laboratories NV has yet to annouce their ex-dividend date. The historic dividend yield on Core Laboratories NV shares is currently 0.81%.

How do I buy Core Laboratories NV shares?

To buy shares in Core Laboratories NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Core Laboratories NV?

Shares in Core Laboratories NV are currently trading at $34.55, giving the company a market capitalisation of £1.11bn.

Where are Core Laboratories NV shares listed? Where are Core Laboratories NV shares listed?

Here are the trading details for Core Laboratories NV:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: CLB
What kind of share is Core Laboratories NV?

Based on an overall assessment of its quality, value and momentum, Core Laboratories NV is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Core Laboratories NV share price forecast 2021?

Shares in Core Laboratories NV are currently priced at $34.55. At that level they are trading at 17.05% premium to the analyst consensus target price of 0.00.

Analysts covering Core Laboratories NV currently have a consensus Earnings Per Share (EPS) forecast of 0.86 for the next financial year.

How can I tell whether the Core Laboratories NV share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Core Laboratories NV. Over the past six months, the relative strength of its shares against the market has been 50.48%. At the current price of $34.55, shares in Core Laboratories NV are trading at 47.22% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Core Laboratories NV PE Ratio?

We were not able to find PE ratio data for Core Laboratories NV.

Who are the key directors of Core Laboratories NV?

Core Laboratories NV's management team is headed by:

Christopher Hill - CFO
Mark Elvig - GCN
Martha Carnes - LED
Michael Straughen - IND
Lawrence Bruno - CSU
Gregory Barnett - IND
Monique Van Dijken Eeuwijk - IND
Harvey Klingensmith - IND
Who are the major shareholders of Core Laboratories NV?

Here are the top five shareholders of Core Laboratories NV based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 10.28% (4.58m shares)
Ariel Investments, LLC Investment Advisor
Percentage owned: 10.14% (4.52m shares)
EARNEST Partners, LLC Investment Advisor/Hedge Fund
Percentage owned: 9.57% (4.27m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 9.3% (4.15m shares)
iShares Core S&P Small-Cap ETF Mutual Fund
Percentage owned: 6.58% (2.93m shares)
Similar to CLB
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.